![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Boddeke E.W.G.M. Meigel I. Frentzel S. Biber K. Renn L.Q. Gebicke-Harter P.
Publisher: Elsevier
ISSN: 0014-2999
Source: European Journal of Pharmacology, Vol.374, Iss.2, 1999-06, pp. : 309-313
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The CX3C-Chemokine Fractalkine in Kidney Diseases
Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation
Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. :